Close Menu

NEW YORK (GenomeWeb) – MDxHealth announced today that it has signed a commercial service agreement with the Fondazione Luigi Maria Monti - Istituto Dermopatico dell' Immacolata (IDI) research Hospital in Rome to provide its SelectMDx prostate cancer test as a service.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.